ActiveSight to Provide Crystallography Services to Inpharmatica
News Nov 23, 2005
ActiveSight has announced that it has signed an agreement to provide structural biology services to Inpharmatica Ltd.
The agreement focuses on co-crystallography by ActiveSight of certain Inpharmatica small molecules with a human drug target protein. The agreement includes upfront fees and payments for milestones.
"ActiveSight is delighted to augment Inpharmatica's unique drug discovery platform," stated Duncan McRee, Ph.D., President of ActiveSight.
18th International Conference on Pharmaceutics & Novel Drug Delivery Systems
May 27 - May 28, 2019
Global Experts Meeting on Frontiers in Biosimilars and Biologics Congress
Oct 24 - Oct 26, 2019